Welcome to our dedicated page for Genpact news (Ticker: G), a resource for investors and traders seeking the latest updates and insights on Genpact stock.
Genpact Limited (NYSE: G) delivers transformative business solutions through digital innovation and process excellence. This news hub provides investors and professionals with essential updates about the company's strategic initiatives, operational developments, and market leadership in business process management.
Access real-time announcements including quarterly earnings disclosures, partnership agreements, technology implementations, and corporate governance updates. Our curated collection ensures you stay informed about Genpact's progress in key focus areas like Data-Tech-AI integration, enterprise transformation projects, and industry-specific solutions across banking, healthcare, and manufacturing sectors.
Discover press releases detailing operational milestones, executive leadership changes, and client success stories. The archive serves as a vital resource for tracking Genpact's commitment to enhancing business agility through intelligent automation and process optimization strategies.
Bookmark this page for continuous access to verified corporate communications and analysis of Genpact's evolving role in shaping digital-first enterprise operations worldwide.
Genpact (NYSE: G) announced the appointment of Tamara Franklin, former Chief Digital, Data, and Analytics Officer at Marsh LLC, to its Board of Directors, effective March 29, 2021. Franklin's extensive experience in digital transformation and leadership roles at IBM and Scripps Networks Interactive is expected to enhance Genpact's strategic initiatives. Chairman Jim Madden and CEO Tiger Tyagarajan expressed optimism about her contributions, emphasizing her expertise in driving innovation and client experience.
On March 24, 2021, Genpact (NYSE: G), alongside the Creative Destruction Lab Rapid Screening Consortium and the COVID Collaborative, launched the U.S. Rapid Action Consortium. This initiative aims to fast-track safe, cost-effective COVID-19 testing to facilitate business reopenings. The Consortium publicizes its findings and testing protocols to support workplaces across the U.S., inspired by a successful Canadian model. The first cohort of participating companies is set to commence on April 5, 2021, amid rising urgency for systematic rapid testing as the economy faces significant losses.
Genpact Limited (NYSE: G) announced a $350 million public offering of 1.750% senior notes due 2026, priced by its subsidiaries, Genpact Luxembourg and Genpact USA. The offering is expected to close on March 26, 2021, pending customary conditions. The proceeds may be used for general corporate purposes, including repaying existing debt. The offering is part of an effective shelf registration with the SEC. Genpact emphasizes its commitment to digital transformation and innovation across its operations, serving numerous Global Fortune 500 clients.
Commonwealth Informatics, a subsidiary of Genpact, launched an upgraded version of its Commonwealth Vigilance Workbench (CVW) on March 22, 2021. This cloud-based solution aims to enhance drug safety through advanced AI and analytics, benefiting life sciences and regulatory agencies. Two major global pharmaceutical companies have implemented the new CVW, which streamlines signal detection and management of adverse drug effects. The latest enhancements improve data review, signal tracking, and report generation. Commonwealth's focus on pharmacovigilance is timely, given the ongoing COVID-19 pandemic.
Genpact (NYSE:G) has secured two patents from the U.S. Patent and Trademark Office for innovative business transformation frameworks: Genpact ProcIndex and Intelligent Automation Index. ProcIndex measures process health using analytics, helping companies identify improvement opportunities, while the Intelligent Automation Index assesses automation potential across processes. By leveraging these tools, Genpact enables firms to drive operational efficiency and optimize ROI. Both frameworks have been successfully implemented by over 100 clients, leading to significant improvements in process efficiency and cost reduction.
Genpact (NYSE: G) has announced an extension of its strategic partnership with Envision Virgin Racing, focusing on digital transformation through 2022. This collaboration aims to enhance the racing team's performance both on and off the track, leveraging data analytics for real-time decision-making. Since 2018, they have co-innovated to reduce climate impact and engage a sustainability-focused fanbase. The partnership emphasizes not just competitive advantage on the racetrack but also a commitment to combating climate change, representing Genpact's role in advancing sustainable practices.
Genpact Limited (NYSE: G) reported its financial results for Q4 and full year 2020, achieving a total revenue of $3.7 billion, a 5% increase year-over-year. Revenue from Global Clients reached $3.3 billion, up 7%, while revenue from GE declined by 4% to $459 million. Net income was $308 million, up 1%, with diluted EPS of $1.57 also up 1%. However, new bookings fell 20%. Looking ahead, Genpact expects 2021 revenue between $3.93 to $3.99 billion, forecasting growth of 6% to 7.5%.
Genpact (NYSE: G) has partnered with Massmart to enhance its finance operations through digital technology and analytics. This collaboration will standardize and automate Massmart's finance and accounting services, including accounts payable and receivable, enhancing real-time visibility and transparency. Genpact will establish finance delivery centers in Johannesburg and Durban, South Africa, transferring affected Massmart employees to its team. This partnership builds on Genpact's relationship with Walmart, Massmart's majority owner, focusing on operational excellence and efficient finance processes.